Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGB | P11216 | 7/20 | 0.65 |
| ▸ | GAA | P10253 | 1/20 | 0.65 |
| ▸ | CA1 | P00915 | 6/20 | 0.57 |
| ▸ | CA2 | P00918 | 6/20 | 0.57 |
| ▸ | CA9 | Q16790 | 6/20 | 0.57 |
| ▸ | CA12 | O43570 | 3/20 | 0.57 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28491648 | 1.00 | PYGB (0.65) | PYGBGAACA1CA2CA9 | |
| SCHEMBL10939188 | 1.00 | PYGB (0.65) | PYGBGAACA1CA2CA9 | |
| SCHEMBL1208980 | 0.98 | PYGB (0.62) | PYGBGAACA1CA2CA9 | |
| SCHEMBL22195972 | 0.98 | PYGB (0.62) | PYGBGAACA1CA2CA9 | |
| SCHEMBL1208976 | 0.98 | PYGB (0.62) | PYGBGAACA1CA2CA9 | |
| SCHEMBL30957909 | 0.85 | PYGB (0.69) | PYGBGAACA1CA2CA9 | |
| SCHEMBL30498599 | 0.84 | CA12 (0.57) | PYGBGAACA1CA2CA9 | |
| SCHEMBL29977113 | 0.84 | CA12 (0.57) | PYGBGAACA1CA2CA9 | |
| SCHEMBL9343539 | 0.83 | PYGB (0.67) | PYGBGAACA1CA2CA9 | |
| SCHEMBL13745906 | 0.83 | PYGB (0.77) | PYGBGAACA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4110344-A2 | USE OF THYROMIMETICS FOR THE TREATMENT OF CANCER | The University Of Vermont (US) | 2023-01-04 | — | — | EP | claimed |
| EP-4110344-A2 | USE OF THYROMIMETICS FOR THE TREATMENT OF CANCER | The University Of Vermont (US) | 2023-01-04 | — | — | EP | disclosed |
| US-7381540-B2 | Composition for measuring glucose having improved substrate specificity | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 2008-06-03 | — | — | US | disclosed |
| US-20070037239-A1 | Lowering reactivity on maltose by reacting modified pyrroloquinoline quinone dependent glucose dehydrogenase with succinic, malonic, glutaric, malic acid and ferricyanide salt | TOYO BOSEKI KABUSHIKI KAISHA (JP) | 2007-02-15 | — | — | US | disclosed |
| EP-1752769-A1 | Composition for measuring glucose having improved substrate specificity | Toyo Boseki Kabushiki Kaisha (JP) | 2007-02-14 | — | — | EP | disclosed |
| JP-2003261591-A | LYOPHILIZATION STABILIZER | HAYADE KOJI | 2003-09-19 | — | — | JP | disclosed |
| EP-0062329-A1 | Novel nitrosourea derivative, process for preparing same and therapeutic composition containing said derivate | Tanabe Seiyaku Co., Ltd. (JP) | 1982-10-13 | — | — | EP | disclosed |